These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36300779)

  • 81. Morphology and clinical characteristics of a case of FIP1L1-RARA fusion-associated variant acute promyelocytic leukemia.
    Feng X; Zheng Y; Xu J
    Leuk Lymphoma; 2023 Feb; 64(2):499-502. PubMed ID: 36351169
    [No Abstract]   [Full Text] [Related]  

  • 82. Acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia.
    Machida H; Shinohara T; Iwahara Y; Hatakeyama N; Okano Y; Nakano M; Hosokawa E; Abe S; Naruse K; Ogushi F
    Intern Med; 2011; 50(24):3037-41. PubMed ID: 22186000
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
    Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
    Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
    [No Abstract]   [Full Text] [Related]  

  • 84. [M3, promyelocytic leukemia].
    Tsuruoka N
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):65-7. PubMed ID: 9851086
    [No Abstract]   [Full Text] [Related]  

  • 85. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.
    Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S
    Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Target acquisition and acute promyelocytic leukemia.
    Egan DA; Evans RM
    J Clin Invest; 1999 May; 103(10):1367-8. PubMed ID: 10330417
    [No Abstract]   [Full Text] [Related]  

  • 87. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
    Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
    Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
    [No Abstract]   [Full Text] [Related]  

  • 88. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
    Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
    Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.
    Borrow J; Solomon E
    Baillieres Clin Haematol; 1992 Oct; 5(4):833-56. PubMed ID: 1339190
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Jansen J; Dejean A
    Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mouse models of acute promyelocytic leukemia.
    Pollock JL; Westervelt P; Walter MJ; Lane AA; Ley TJ
    Curr Opin Hematol; 2001 Jul; 8(4):206-11. PubMed ID: 11561157
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.
    Cheng CK; Chan HY; Yung YL; Wan TSK; Leung AWK; Li CK; Tian K; Chan NPH; Cheung JS; Ng MHL
    Blood Adv; 2022 Jan; 6(2):410-415. PubMed ID: 34673934
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
    Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
    Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
    [No Abstract]   [Full Text] [Related]  

  • 95. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
    Park JP; Fairweather RB; Mohandas TK
    Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
    [No Abstract]   [Full Text] [Related]  

  • 97. Role of the promyelocytic leukaemia protein in cell death regulation.
    Salomoni P; Dvorkina M; Michod D
    Cell Death Dis; 2012 Jan; 3(1):e247. PubMed ID: 22237204
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
    Zhang X; Pan J
    Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
    [No Abstract]   [Full Text] [Related]  

  • 99. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
    Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
    Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
    [No Abstract]   [Full Text] [Related]  

  • 100. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.
    Yamamoto Y; Tsuzuki S; Tsuzuki M; Handa K; Inaguma Y; Emi N
    Blood; 2010 Nov; 116(20):4274-83. PubMed ID: 20807888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.